Dividend increased approximately 8% and $581 million in share repurchases executed from a new $1.5 billion authorization.

Main market opportunities lie in sustainable water management, advanced membrane bioreactors, and technological integration with AI and IoT. Rising demand for cleaner water and regulatory compliance ...

The review brings together insights from BCC Research reports on pharmaceutical filtration, smart water management, membrane ...

The S&P 500 continued to rise with Big Tech earnings on tap. Expectations are sky high.

Xylem reported first-quarter 2026 orders of $2.2 billion, up 3% from a year earlier, with organic orders flat. Revenue rose 3 ...

Zimmer Biomet said Chief Financial Officer Suketu Upadhyay will leave the company effective April 28, ending a seven-year run ...

Xylem's Q1 revenue grew 3% to $2.13B, supported by water infrastructure and measurement solutions. Learn why XYL stock is a ...

First-Quarter Highlights Orders of $2.2 billion, up 3% on a reported basis and flat organically Revenue of $2.1 billion, up 3 ...

Recent expectations for higher earnings and revenues have put Xylem (XYL) in focus, as investors weigh upbeat sentiment against its role in the expanding global water reuse and treatment markets, ...

“A Rumor of War,” about his service as a Marine Corps infantry officer and published in 1977, relentlessly detailed “the things men do in war and the things war does to them.” By Joseph Berger Her ...

Her time in concentration camps brought her an understanding of humanity that helped her treat her patients. By Richard Sandomir “A Rumor of War,” about his service as a Marine Corps infantry officer ...

This Review discusses the expression and maturation of human cytoplasmic tRNAs and recent insights into their regulation of translation. The authors also explore emerging roles of tRNAs in ...